Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 296,559 $ 278,626
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion expense 3,056 1,148
Depletion, depreciation and amortization 352,848 254,887
Stock-based compensation expense 5,792 4,793
(Income) loss from equity investments (35,040) 34,018
Change in fair value of derivative instruments 106,373 (129,692)
Deferred income tax benefit (69) 0
Amortization of loan commitment fees 4,554 3,548
Gain on sale of equity method investments (124,768) (12,523)
Distributions from equity method investments 1,978 0
Changes in operating assets and liabilities:    
Increase in accounts receivable—oil and natural gas sales (10,618) (20,056)
Increase in accounts receivable—joint interest and other (2,277) (23,289)
Increase in accounts receivable—related parties (79) (346)
Increase in prepaid expenses and other current assets (4,830) (2,531)
Decrease (increase) in other assets 1,228 (5,665)
Increase in accounts payable, accrued liabilities and other 14,968 111,335
Settlement of asset retirement obligation (719) (2,520)
Net cash provided by operating activities 608,956 491,733
Cash flows from investing activities:    
Additions to other property and equipment (7,134) (16,288)
Acquisition of oil and natural gas properties 0 (1,339,456)
Additions to oil and natural gas properties (755,263) (789,743)
Proceeds from sale of oil and natural gas properties 4,820 4,079
Proceeds from sale of other property and equipment 217 658
Proceeds from sale of equity method investments 226,487 0
Contributions to equity method investments (2,318) (44,844)
Distributions from equity method investments 446 4,114
Net cash used in investing activities (532,745) (2,181,480)
Cash flows from financing activities:    
Principal payments on borrowings (165,428) (183)
Borrowings on line of credit 225,000 365,000
Borrowings on term loan 0 2,951
Debt issuance costs and loan commitment fees (772) (8,261)
Payments on repurchase of stock (109,997) 0
Proceeds from issuance of common stock, net of offering costs 0 (5,364)
Net cash (used in) provided by financing activities (51,197) 354,143
Net increase (decrease) in cash, cash equivalents and restricted cash 25,014 (1,335,604)
Cash, cash equivalents and restricted cash at beginning of period 99,557 1,460,875
Cash, cash equivalents and restricted cash at end of period 124,571 125,271
Supplemental disclosure of cash flow information:    
Interest payments 75,045 50,826
Income tax payments 0 0
Supplemental disclosure of non-cash transactions:    
Capitalized stock-based compensation 3,862 3,195
Asset retirement obligation capitalized 1,094 11,557
Interest capitalized 3,956 8,753
Foreign currency translation (loss) gain on equity method investments $ (5,815) $ 12,719